- Home
- SNGX vs CELZ Comparison
SNGX vs CELZ Comparison
Compare SNGX & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- CELZ
- Stock Information
- Founded
- SNGX 1987
- CELZ 1998
- Country
- SNGX United States
- CELZ United States
- Employees
- SNGX N/A
- CELZ N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- SNGX Health Care
- CELZ Health Care
- Exchange
- SNGX Nasdaq
- CELZ Nasdaq
- Market Cap
- SNGX 6.1M
- CELZ 5.5M
- IPO Year
- SNGX 1987
- CELZ N/A
- Fundamental
- Price
- SNGX $1.90
- CELZ $2.18
- Analyst Decision
- SNGX
- CELZ
- Analyst Count
- SNGX 0
- CELZ 0
- Target Price
- SNGX N/A
- CELZ N/A
- AVG Volume (30 Days)
- SNGX 29.1K
- CELZ 127.1K
- Earning Date
- SNGX 05-09-2025
- CELZ 05-09-2025
- Dividend Yield
- SNGX N/A
- CELZ N/A
- EPS Growth
- SNGX N/A
- CELZ N/A
- EPS
- SNGX N/A
- CELZ N/A
- Revenue
- SNGX $119,371.00
- CELZ $11,000.00
- Revenue This Year
- SNGX N/A
- CELZ N/A
- Revenue Next Year
- SNGX N/A
- CELZ N/A
- P/E Ratio
- SNGX N/A
- CELZ N/A
- Revenue Growth
- SNGX N/A
- CELZ 22.22
- 52 Week Low
- SNGX $1.83
- CELZ $1.92
- 52 Week High
- SNGX $14.88
- CELZ $6.90
- Technical
- Relative Strength Index (RSI)
- SNGX 33.66
- CELZ 36.34
- Support Level
- SNGX $2.25
- CELZ $1.95
- Resistance Level
- SNGX $2.28
- CELZ $2.50
- Average True Range (ATR)
- SNGX 0.11
- CELZ 0.34
- MACD
- SNGX -0.02
- CELZ -0.06
- Stochastic Oscillator
- SNGX 0.11
- CELZ 22.54
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.